Strides Pharma Science Ltd Share Price

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

NSE: STAR Small Cap ISIN: INE939A01011

As on 22 January 2025 at 18:36 IST

₹581.30

+ 10.70

(1.88%)

Sell Buy

Over 1 Month

-18.40%

Over 6 Months

36.87%

Over 1 Year

99.43%

Over 3 Years

224.85%

Strides Pharma Science Ltd Summary

Close ₹ 581.30

Open ₹ 570.60

High ₹ 588

Low ₹ 549

Volume 16,60,225

Net Turnover (in ₹) ₹ 36,44,22,394

52Wk High ₹ 753.90

52Wk Low ₹ 282.11

52Wk High / Low

282.11

753.90

Strides Pharma Science Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 5,258.80

EPS (TTM) 8.50

Book Value (BV) 381.63

Div. Yield 0.44 %

P/E (TTM) 71.11

Price/Book Value 1.49

Delivery % 62.92 %

Face Value 10

Key Ratios

PE Ratio 109.76

PB Ratio 2.02

EV to Sales 4.05

PEG Ratio 0.09

ROA 1.25

ROE 1.87

Debt-Equity 0.44

Net Profit Margin 3.04

Operating Profit Margin 14.96

Strides Pharma Science Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	4,090.82	3,778.72	3,202.24	3,367.30	2,805.08
Total Expenses	3,842.99	3,762.60	3,500.11	3,037.39	2,565.49
Profit Before Tax	-116.94	-286.20	-652.51	275.44	54.68
Profit After Tax	-148.53	-230.90	-474.25	243.79	43.36
Operating Profit after Depreciation	562.28	277.26	-121.13	479.97	395.31

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	1,935.19	2,401.14	2,568.30	2,370.90	2,290.74
Total Non Current Assets	2,870.76	3,395.06	3,614.03	4,197.79	3,779.62
Total Current Assets	2,969	3,243.36	3,361.83	2,817.23	2,372.11
TOTAL ASSETS	5,839.76	6,638.42	6,975.86	7,015.02	6,151.73
Total Shareholder's Fund	2,125.56	2,212.26	2,359.23	2,776.66	2,527.42

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	701.07	44.41	-257.82	481.44	204.79
Net Cash used in Investing Activities	-150.22	302.28	-118.61	-522.04	1,321.01
Net Cash used in Financing Activities	-693.32	-213.92	421.32	-15.80	-1,709.45

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	2,225.56	1,938.56	2,102.49	1,974.65	1,785
Total Expenses	2,150.58	1,988.32	2,080.98	1,863.02	1,648.56
Profit Before Tax	69.62	-64.76	21.51	111.64	136.44
Profit After Tax	65.49	4.68	180.19	78.24	120.28
Operating Profit after Depreciation	242.91	88.92	95.75	176.97	203.29

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	580.88	623.89	629.36	605.97	601.13
Total Non Current Assets	3,421.93	3,493.34	3,458.61	3,477.48	3,281.33
Total Current Assets	2,415.86	2,126.40	1,975.25	1,743.86	1,395.53
TOTAL ASSETS	5,837.78	5,619.74	5,433.86	5,221.33	4,676.86
Total Shareholder's Fund	3,561.12	3,455.05	3,406.68	3,248.06	3,158.79

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	-35.76	241.74	-282.69	282.76	137.64
Net Cash used in Investing Activities	-61.27	-182.58	18.78	-275.64	62.83
Net Cash used in Financing Activities	107.62	10.82	250.73	-48.64	-203.56

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	1,201.11	1,087.51	1,084.04	1,037.67	999.43
Total Expenses	978.12	882.33	902.88	895.83	888.55
Profit Before Tax	114.86	85.18	29.69	64.16	-156.90
Profit After Tax	93.66	68.31	10.44	54.06	-149.46
Operating Profit after Depreciation	251.40	217.90	167.68	204.74	146.73

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	609.96	585.95	617.63	520.02	552.60
Total Expenses	546.93	520.19	526.84	454.36	514.16
Profit Before Tax	14.44	3.56	52.77	3.53	-6.85
Profit After Tax	15.31	2.40	53.66	2.54	-6.75
Operating Profit after Depreciation	86.58	73.85	120.42	74.35	57.90

Strides Pharma Science Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 553.22

S2 535.83

S3 504.87

Pivot 584.18

R1 601.57

R2 632.53

R3 649.92

Moving Average

20 SMA 654.24

50 SMA 666.87

100 SMA 651.69

200 SMA 536.24

Strides Pharma Science Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

Strides Pharma Science Ltd

₹2.5/Share

Announcement Date 09 Sep 2024

Record Date 09 Sep 2024

Div Yield 25%

AGM Date: 09 Sep 2022

AGM 09/09/2022 This is to inform you that the 31st Annual General Meeting (AGM) of the Company is scheduled to be held on Friday, September 9, 2022, at 12:30 hrs IST through Video Conference/ Other Audio-Visual Means. As required under SEBI Listing Regulations, we are enclosing herewith Notice of the AGM and Annual Report for FY 2021-22 which is being sent through electronic mode to the Members of the Company. A copy of the same is also available on the Company's website www.strides.com This is for your information and records. (As Per BSE Announcement Dated on 18.08.2022) We wish to inform you that the 31st AGM of the Company was held on Friday, September 9, 2022 through Video Conference. Pursuant to Regulation 30, Part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed the summary of proceedings of the AGM. This is for your information and records. (As Per BSE Announcement dated on 09.09.2022) Outcome of the 31st Annual General Meeting of the Company Strides Pharma Science Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on 10.09.2022)

AGM Date: 28 Aug 2023

Newspaper advertisement titled - Intimation about 32nd Annual General Meeting of the Company and Record Date for Dividend. Newspaper Publication title ''Notice of 32nd Annual General Meeting, Remote E-Voting and Cut-Off Date'' (As Per BSE Announcement Dated on 05.08.2023) Outcome of the 32nd Annual General Meeting of Strides Pharma Science Limited - Disclosure under SEBI Listing Regulations Outcome of the 32nd Annual General Meeting of Strides Pharma Science Limited - Disclosure under SEBI Listing Regulations (As Per BSE Announcement Dated on 30.08.2023)

AGM Date: 25 Sep 2024

AGM 25/09/2024 Annual Report for FY24 (As Per BSE Announcement Dated on: 02/09/2024) Announcement of Proceedings of the 33rd Annual General Meeting of the Company. (As Per BSE Announcement Dated on 25.09.2024) Scrutinizers report for Strides 33rd Annual General Meeting. (As Per Bse Announcement Dated on 26.09.2024)

EGM Date: 30 Mar 2022

Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') Intimation regarding rescheduling of Extraordinary General Meeting (As Per BSE Announcement Dated on 17.02.2022)

EGM Date: 07 Apr 2022

EGM 07/04/2022 Update on Proposed Preferential Issue We wish to inform you that the EGM of the Company was held on Thursday, April 7, 2022 through Video Conference. Pursuant to Regulation 30, Part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed the summary of proceedings of the EGM. This is for your information and records. We wish to inform you that the EGM of the Company was held on Thursday, April 7, 2022 through Video Conference. Pursuant to Regulation 30, Part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed the revised summary of proceedings of the EGM. This is for your information and records. (As Per BSE Announcement Dated 07.04.2022) Outcome of the Extraordinary General Meeting of the Company (As per BSE Announcement Dated on 9/4/2022) Strides Pharma Science Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here (As Per BSE Announcement Dated 11.04.2022)

EGM Date: 06 Feb 2023

EGM 06/02/2023 Notice of Extraordinary General Meeting of the shareholders of the Company scheduled to be held on February 6, 2023 at 12:30 hrs IST through Video Conference/ Other Audio-Visual Means. (As Per BSE Bulletin Dated on 13.01.2023) We wish to inform you that EGM of the Company was held on Monday, February 6, 2023 through Video Conference. Pursuant to Regulation 30, Part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed the summary of proceedings of EGM. Outcome of the Extraordinary General Meeting of the Company held on February 6, 2023 (As Per BSE Announcement Dated on 06.02.2023)

EGM Date: 10 Sep 2024

COM 10/09/2024 Outcome of NCLT Convened meeting - Approval from Equity shareholders and Secured Creditors for creation of OneSource - India''s first Specialty Pharma CDMO (As Per BSE Announcement dated on 11.09.2024)

Strides Pharma Science Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Strides Pharma Science Ltd	₹570.30	₹5,256.04
Sun Pharmaceuticals Industries Ltd	₹1,761.80	₹4,22,714.84
Divis Laboratories Ltd	₹5,818.40	₹1,54,460.24
Cipla Ltd	₹1,427.30	₹1,15,270.75
Dr Reddys Laboratories Ltd	₹1,288.45	₹1,07,511.36
Torrent Pharmaceuticals Ltd	₹3,157.60	₹1,06,862.73

Strides Pharma Science Ltd News

Strides Pharma Science Ltd leads gainers in 'A' group

Authum Investment & Infrastructure Ltd, Century Plyboards (India) Ltd, Tanla Platforms Ltd and Amber Enterprises India Ltd are among the other gainers in the BSE's 'A' group today, 01 January 2025.

01 Jan 2025, 12:00 pm

Strides Pharma Science Ltd leads losers in 'A' group

CARE Ratings Ltd, Avalon Technologies Ltd, Adani Green Energy Ltd and Easy Trip Planners Ltd are among the other losers in the BSE's 'A' group today, 04 December 2024.

04 Dec 2024, 03:00 pm

Strides Pharma Science allots 2.04 lakh equity shares under ESOP

29 Nov 2024, 12:31 pm

OneSource Specialty Pharma successfully raises Rs 801 cr via equity issuance

25 Nov 2024, 03:30 pm

Strides Pharma jumps on securing NCLT nod for OneSource

Strides Pharma Science jumped 6.82% to Rs 1487.50 after the National Company Law Tribunal (NCLT) gave the green light to the formation of OneSource Specialty Pharma.

21 Nov 2024, 02:49 pm

Strides Pharma Science Ltd Stock Analysis

Annual revenue for Strides Pharma Science Ltd increased by 14.80% to ₹2,225.56 crore in FY 2024 from ₹1,938.56 crore in FY 2023.
Annual Net Profit for Strides Pharma Science Ltd increased by 1298.78% to ₹65.49 crore in FY 2024 from ₹4.68 crore in FY 2023.
Promoter Shareholding in Strides Pharma Science Ltd increased by 3.81% in the most recent quarter, from 25.84% in September 2024 to 26.82% in December 2024.
Strides Pharma Science Ltd delivered a 1-year return of 99.43% compared to the Nifty 50, which provided a return of 8.41% as of the last trading session.
Strides Pharma Science Ltd share price moved up by 1.88% from its previous close of INR ₹570.60. The latest Strides Pharma Science Ltd share price is INR ₹581.30.
Strides Pharma Science Ltd share price today has been at a low of 549 and a high of 588. Over the past 52 weeks, the Strides Pharma Science Ltd share price has seen a low of 282.11 and a high of 753.90.